BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34525196)

  • 21. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
    Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.
    Mayerhoefer ME; Raderer M; Weber M; Lamm W; Kiesewetter B; Hacker M; Nics L; Schmitl S; Leithner D; Wester HJ; Haug A
    Clin Nucl Med; 2023 Jul; 48(7):557-562. PubMed ID: 37272977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Sugizaki K; Tari A; Kitadai Y; Oda I; Nakamura S; Yoshino T; Sugiyama T
    Helicobacter; 2018 Apr; 23(2):e12474. PubMed ID: 29504247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
    Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
    Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F
    Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
    Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
    Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI.
    Starzer AM; Berghoff AS; Traub-Weidinger T; Haug AR; Widhalm G; Hacker M; Rausch I; Preusser M; Mayerhoefer ME
    Clin Nucl Med; 2021 Jan; 46(1):16-20. PubMed ID: 33208624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endoscopic ultrasound (EUS) in initial assessment and follow-up of patients with MALT lymphoma treated drug therapy].
    Pavlović AR; Krstić M; Tomić D; Bjelović M; Jesić R; Suvajdzić N
    Acta Chir Iugosl; 2005; 52(1):83-9. PubMed ID: 16119319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.